Medical cannabis stocks and stocks of cannabinoid drug companies are rallying big time Wednesday, the catalyst being a multi-billion-dollar buyout in the space.
What Happened: GW Pharmaceuticals GWPH, which markets plant-derived cannabinoid epilepsy drug Epiodiolex, announced a deal to be bought by Jazz Pharmaceuticals JAZZ for $7.2 billion in cash and stock.
The Sympathy Move: The news has set in motion across-the-board strength in cannabinoid drug companies such as Corbus Pharmaceuticals Holdings Inc CRBP, Zynerba Pharmaceuticals Inc ZYNE, and Cara Therapeutics Inc CARA.
Corbus is a Phase 3 biopharma that is developing lenabasum, an oral, selective cannabinoid receptor type 2 agonist for indications such as systemic sclerosis, cystic fibrosis, dermatomyositis and systemic lupus erythematosus.
Zynerba's lead asset Zygel is a cannabidiol gel that is currently being evaluated for Fragile X syndrome, autism spectrum disorder in pediatric patients, 22q, and a heterogeneous group of rare and ultra-rare epilepsies known as developmental and epileptic encephalopathies.
Cara has in its pipeline a cannabinoid compound CR701, which is a synthetic cannabinoid receptor agonist being evaluated for the treatment of neuropathic pain, particularly for hyperalgesia and allodynia.
Related Link: CBD Vs. THC: The Science Behind The Most Popular Cannabinoids
Other companies with ties to the medical cannabis space such as Hexo Corp HEXO, Tilray Inc TLRY, and Aphria Inc APHA and Akerna Corp KERN, a technology company providing support function to cannabis companies by way of an enterprise resource planning system, are also partaking in the rally.
The strength is attributable to hopes that the sector may see more M&A down the line, with some of these companies likely to be attractive acquisition targets.
The Price Action: In premarket trading Wednesday:
- Corbus shares were up 12.02% to $2.89.
- Zynerba was jumping 16.29% to $4.14.
- Cara shares were rallying 5.06% to $19.74.
- Hexo was moving up 3.37% to $7.36.
- Tilray shares was jumping 8.64% to $25.52.
- Aphria was gaining 5.43% to $15.44.
- Akerna was advancing 3.39% to $7.33.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!